| AI-CAH | autoimmune-type chronic active hepatitis |
|---|---|
| CAAH | chronic active autoimmune hepatitis |
| CALH | chronic active lupoid hepatitis |
| CBH | chronic benign hepatitis; cutaneous basophilic hypersensitivity |
| CHB | chronic hepatitis B; complete heart block; congenital heart block |
| interstitial radiation therapy | <oncology> The implantation of radioactive seeds directly into a tumour. (10 Jan 1998) |
|---|---|
| interstitial therapy | Radiation therapy by means of radioactive seeds or needles implanted directly into the tissues to be irradiated. (05 Mar 2000) |
| interstitial tissue | <pathology> Rather general term for mesodermally derived tissue that may be more or less specialised. Cartilage and bone are specialised connective tissue, as is blood, but the term is probably better reserved for the less specialised tissue that is rich in extracellular matrix (collagen, proteoglycan etc.) and that surrounds other more highly ordered tissues and organs. (18 Nov 1997) |
| usual interstitial pneumonia of Liebow | A progressive inflammatory condition starting with diffuse alveolar damage and resulting in fibrosis and honeycombing over a variable time period; also a common feature of collagen-vascular diseases. Synonym: fibrosing alveolitis, Hamman-Rich syndrome, idiopathic interstitial fibrosis. (05 Mar 2000) |
| lung diseases, interstitial | A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. "interstitial" refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. (12 Dec 1998) |
| lymphocytic interstitial pneumonia | A rare disease characterised by interstitial accumulation of lymphocytes in the lungs and late fibrosis; usually a result of a lymphoma, occasionally seen in AIDS, especially. In children. Sometimes seen as an autoimmune disorder. Synonym: lymphocytic interstitial pneumonia, lymphoid interstitial pneumonia. (05 Mar 2000) |
| lymphocytic interstitial pneumonitis | A rare disease characterised by interstitial accumulation of lymphocytes in the lungs and late fibrosis; usually a result of a lymphoma, occasionally seen in AIDS, especially. In children. Sometimes seen as an autoimmune disorder. Synonym: lymphocytic interstitial pneumonia, lymphoid interstitial pneumonia. (05 Mar 2000) |
| lymphoid interstitial pneumonia | A rare disease characterised by interstitial accumulation of lymphocytes in the lungs and late fibrosis; usually a result of a lymphoma, occasionally seen in AIDS, especially. In children. Sometimes seen as an autoimmune disorder. Synonym: lymphocytic interstitial pneumonia, lymphoid interstitial pneumonia. (05 Mar 2000) |
| lymphoid interstitial pneumonitis | <pathology> A form of pneumonia which is characterised by diffuse interstitial infiltrates and infiltration of lymphocytes into the lung tissue. (27 Sep 1997) |
| acute parenchymatous hepatitis | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| anicteric hepatitis | Hepatitis without jaundice. (05 Mar 2000) |
| anicteric virus hepatitis | A relatively mild hepatitis, without jaundice, due to a virus; the principal physical signs and symptoms are enlargement of the liver, lymph nodes, and often the spleen, together with headache, continuous fatigue, nausea, anorexia, sudden distaste for smoking, abdominal pains, and sometimes mild fever; labratory tests reveal evidence of hepatitis. (05 Mar 2000) |
| autoimmune hepatitis | <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver. Symptoms are those of chronic active hepatitis. (27 Sep 1997) |
| vaccination, hepatitis a | When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. (12 Dec 1998) |
| vaccination, hepatitis b | Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection. (12 Dec 1998) |